GU Cancers 2020 | KRAS G12C target for urothelial carcinoma

VJOncology is committed to improving our service to you

Petros Grivas

Petros Grivas, MD, PhD, University of Washington, Seattle, WA, discusses KRAS G12C as an emerging target for urothelial carcinoma and the ongoing research into this rare, although important mutation. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter